Compile Data Set for Download or QSAR
Report error Found 156 Enz. Inhib. hit(s) with all data for entry = 11585
TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629099(US20230339900, Example 76 | 3-Chloro-4-[3-(5-fluor...)
Affinity DataIC50: 17nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629098(US20230339900, Example 75 | 3-Bromo-4-[3-(5-fluoro...)
Affinity DataIC50: 24nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629074(US20230339900, Example 51 | 4-(3-(5-Fluoropyridin-...)
Affinity DataIC50: 28nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629142(US20230339900, Example 119 | 4-[3-(5-Fluoro-2-pyri...)
Affinity DataIC50: 32nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629103(US20230339900, Example 80 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 41nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629101(US20230339900, Example 78 | 5-Fluoro-4-[3-(5-fluor...)
Affinity DataIC50: 50nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629102(US20230339900, Example 79 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 52nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629100(US20230339900, Example 77 | 3-Fluoro-4-[3-(5-fluor...)
Affinity DataIC50: 53nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629043(US20230339900, Example 20 | US20230339900, Example...)
Affinity DataIC50: 54nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629105(US20230339900, Example 82 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 59nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629043(US20230339900, Example 20 | US20230339900, Example...)
Affinity DataIC50: 70nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629112(US20230339900, Example 89 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 71nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629139(US20230339900, Example 116 | N-(4-(3-(5-Fluoropyri...)
Affinity DataIC50: 76nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629060(US20230339900, Example 37 | 4-[3-(3,5-Difluoro-2-p...)
Affinity DataIC50: 78nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629091(US20230339900, Example 68 | 4-[1-(2-Fluoroethyl)-3...)
Affinity DataIC50: 80nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629078(US20230339900, Example 55 | 4-[1-Ethyl-3-(5-fluoro...)
Affinity DataIC50: 93nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629110(US20230339900, Example 87 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 94nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629081(US20230339900, Example 58 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 97nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629151(US20230339900, Example 128 | 2-Ethoxy-8-[3-(5-fluo...)
Affinity DataIC50: 103nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629024(US20230339900, Example 1 | N-(4-(3-(5-Fluoropyridi...)
Affinity DataIC50: 107nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629094(US20230339900, Example 71 | 4-(1-Cyclobutyl-3-(5-f...)
Affinity DataIC50: 113nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629084(4-[3-(5-Fluoro-2-pyridyl)-1-isobutyl-pyrazol-4-yl]...)
Affinity DataIC50: 115nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629073(US20230339900, Example 50 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 122nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629030(US20230339900, Example 7 | 2-(1-Methyl-4-(1H-pyrro...)
Affinity DataIC50: 128nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629095(US20230339900, Example 72 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 136nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629111(US20230339900, Example 88 | 4-[3-(5-Fluoro-2-pyrid...)
Affinity DataIC50: 144nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629126(US20230339900, Example 103 | 8-[3-(5-Fluoro-2-pyri...)
Affinity DataIC50: 147nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629119(US20230339900, Example 96 | 3-(4-(3-(5-Fluoropyrid...)
Affinity DataIC50: 148nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629051(US20230339900, Example 28 | 4-[3-(6-Fluoro-3-pyrid...)
Affinity DataIC50: 165nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629088(US20230339900, Example 65 | 4-[1-(Difluoromethyl)-...)
Affinity DataIC50: 171nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629050(US20230339900, Example 27 | 4-[3-(4-Fluoro-2-pyrid...)
Affinity DataIC50: 178nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629038(US20230339900, Example 15 | 3-(1-Methyl-4-(1H-pyrr...)
Affinity DataIC50: 181nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629115(US20230339900, Example 92 | 4-(3-(5-Fluoropyridin-...)
Affinity DataIC50: 184nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629052(US20230339900, Example 29 | 4-[3-(6-Fluoro-2-pyrid...)
Affinity DataIC50: 186nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629117(US20230339900, Example 94 | 3-(4-(3-(5-Fluoropyrid...)
Affinity DataIC50: 187nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629123(US20230339900, Example 100 | 4-[3-(5-Fluoro-2-pyri...)
Affinity DataIC50: 197nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629079(US20230339900, Example 56 | 4-(1-Ethyl-3-(5-fluoro...)
Affinity DataIC50: 205nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629097(US20230339900, Example 74 | (R/S)-4-[3-(5-Fluoro-2...)
Affinity DataIC50: 218nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629080(US20230339900, Example 57 | 4-(1-Ethyl-3-(5-fluoro...)
Affinity DataIC50: 219nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629107(US20230339900, Example 84 | 2-(Difluoromethyl)-4-(...)
Affinity DataIC50: 224nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629075(US20230339900, Example 52 | 4-(5-Cyclobutyl-3-(5-f...)
Affinity DataIC50: 227nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629146(US20230339900, Example 123 | 4-[3-(5-Fluoro-2-pyri...)
Affinity DataIC50: 234nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629093(US20230339900, Example 70 | 4-(3-(5-Fluoropyridin-...)
Affinity DataIC50: 236nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629122(US20230339900, Example 99 | 4-(3-(5-Fluoropyridin-...)
Affinity DataIC50: 238nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629047(US20230339900, Example 24 | 4-[3-(5-Chloro-2-pyrid...)
Affinity DataIC50: 251nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629086(US20230339900, Example 63 | 4-(3-(5-Fluoropyridin-...)
Affinity DataIC50: 253nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629108(US20230339900, Example 85 | 4-(3-(5-Fluoropyridin-...)
Affinity DataIC50: 255nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629130(US20230339900, Example 107 | 4-[3-(5-Fluoro-2-pyri...)
Affinity DataIC50: 264nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629066(US20230339900, Example 43 | 4-[3-(5-Fluoropyrimidi...)
Affinity DataIC50: 268nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629063(US20230339900, Example 40 | 4-(3-(5-Fluoro-6-methy...)
Affinity DataIC50: 288nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/10/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 156 total ) | Next | Last >>
Jump to: